An open label study of clobetasol propionate 0.05% and betamethasone valerate 0.12% foams in the treatment of mild to moderate acne keloidalis

Cutis

Volumn 75, Issue 6, 2005, Pages 317-321

  Callender, Valerie D ^a   Young, Cherie M ^a   Haverstock, Christina L ^b   Carroll, Christie L ^b   Feldman, Steven R ^b  

^a Callender Skin and Laser Center   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE VALERATE; CLOBETASOL PROPIONATE; STEROID;

ACNE; ADULT; AFRICAN AMERICAN; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSAGE FORM; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INDICATION; DRUG TOLERABILITY; FEMALE; FOLLICULITIS KELOIDALIS; HUMAN; MALE; PREVALENCE; SEX DIFFERENCE; TOPICAL TREATMENT;

ACNE KELOID; ADMINISTRATION, TOPICAL; ADULT; AFRICAN AMERICANS; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE 17-VALERATE; CLOBETASOL; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SCALP DERMATOSES; TREATMENT OUTCOME;

EID: 21344444374     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Adamson H. Dermatitis papillaris capillitii (Kaposi): acne keloid. Br J Dermatol. 1914;26:83.
2. Cosman B, Wolff M. Acne keloidalis. Plast Reconstr Surg. 1972;50:25-30.
3. Fox H. "Folliculitis keloidalis" is a better term than "dermatitis papillaris capillitii." Arch Dermatol Syph. 1942;55:112-113.
4. Dinehart SM, Herzberg AJ, Kerns BJ, et al. Acne keloidalis: a review. J Dermatol Surg Oncol. 1989;15:642-647.
5. Dinehart SM, Tanner L, Mallory SB, et al. Acne keloidalis in women. Cutis. 1989;44:250-252.
6. Fox H. Observations of skin diseases in the negro. J Cutan. 1908;26:67-79.
7. George AO, Akanji AO, Nduka EU, et al. Clinical, biochemical and morphologic features of acne keloidalis in a black population. Int J Dermatol. 1993;32:714-716.
8. Child FJ, Fuller LC, Higgins EM, et al. A study of the spectrum of skin disease occurring in a black population in south-east London. Br J Dermatol. 1999;141:512-517.
9. Halder RM, Grimes PE, McLaurin CI, et al. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis. 1983;32:388, 390.
10. Kenney JA Jr. Management of dermatoses peculiar to negroes. Arch Dermatol. 1965;91:126-129.
11. Knable AL Jr, Hanke CW, Gonin R. Prevalence of acne keloidalis nuchae in football players. J Am Acad Dermatol. 1997;37:570-574.
12. Grunwald MH, Ben Dor D, Livni E, et al. Acne keloidalis-like lesions on the scalp associated with antiepileptic drugs. Int J Dermatol. 1990;29:559-561.
13. Halder RM. Pseudofolliculitis barbae and related disorders. Dermatol Clin. 1988;6:407-412.
14. Sperling LC. Acne keloidalis (folliculitis keloidalis). In: An Atlas of Hair Pathology With Clinical Correlations. New York, NY: Parthenon Publishing; 2003:119-123.
15. Macguire HC Jr. Treatment of keloids with triamcin-olone acetonide injected intralesionally. JAMA. 1965;192:325-326.
16. Layton AM, Yip J, Cunliffe WJ. A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids. Br J Dermatol. 1994;130:498-501.
17. Gloster HM Jr. The surgical management of extensive cases of acne keloidalis nuchae. Arch Dermatol. 2000;136:1376-1379.
18. Kantor GR, Ratz JL, Wheeland RG. Treatment of acne keloidalis nuchae with carbon dioxide laser. J Am Acad Dermatol. 1986;14:263-267.
19. Glenn MJ, Bennett RG, Kelly AP. Acne keloidalis nuchae: treatment with excision and second-intention healing. J Am Acad Dermatol. 1995;33:243-246.
20. Pestalardo CM, Cordero A Jr, Ansorena JM, et al. Acne keloidalis nuchae. tissue expansion treatment. Dermatol Surg. 1995;21:723-724.